DNA repair enzyme identified as a potential brain cancer drug target
Tuesday, January 5, 2016 - 14:35
in Health & Medicine
When they removed Dicer from preclinical models of medulloblastoma, a common type of brain cancer in children, researchers found high levels of DNA damage in the cancer cells, leading to the cells’ death. The tumor cells were smaller, and also more sensitive to chemotherapy, they report.